|
|
Vaccine Detail
|
ARCT-021 |
| Vaccine Information |
- Vaccine Name: ARCT-021
- Target Pathogen: SARS-CoV-2
- Target Disease: COVID-19
- Product Name: LUNAR-COV19
- Vaccine Ontology ID: VO_0005164
- Type: RNA vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Antigen: spike (S) protein gene (Saha et al., 2020)
- Immunization Route: Intramuscular injection (i.m.)
- Description: A SARS-CoV-2 investigational vaccine comprising a self-replicating (replicon) mRNA that encodes for the prefusion spike protein of 2019-nCoV formulated in a lipid nanoparticle (Saha et al., 2020)
|
| Host Response |
|
|
| References |
Saha et al., 2020: Saha RP, Sharma AR, Singh MK, Samanta S, Bhakta S, Mandal S, Bhattacharya M, Lee SS, Chakraborty C. Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19. Frontiers in pharmacology. 2020; 11; 1258. [PubMed: 32973505].
|
|
